Viewing Study NCT01068860

Home Icon Home Search Icon Search Certify Doc Icon Certify Doc Certify Doc Icon Genes Certify Doc Icon Clinical Trials Certify Doc Icon CompTox Processes Icon DrugMatrix Open Targets Icon Open Targets Processes Icon Products Support Icon Support Bugs Icon Bugs
Main Search Make This Study a Gene Therapy Make This Study a Not Gene Therapy Report Bug
Ignite Creation Date: 2025-12-25 @ 2:11 AM
Ignite Modification Date: 2026-05-05 @ 1:52 AM
Study NCT ID: NCT01068860
Status: COMPLETED
Last Update Posted: 2011-09-05
First Post: 2010-02-12
Is Gene Therapy: True
Has Adverse Events: True
Brief Title: To Compare the Effect of a Subcutaneous Canakinumab Administration to Placebo in Patients With Impaired Glucose Tolerance or Patients With Type 2 Diabetes With Differing Baseline Diabetes Therapies
Sponsor: Novartis
Organization:
Overview Dates Organization Conditions Design Enrollment Locations Outcomes Modules Raw JSON

Conditions & Keywords Data

Conditions:

Conditions

Condition Brief Condition Text View
None Type 2 Diabetes Mellitus View
None Impaired Glucose Tolerance View
Keywords:

Keywords

Keyword Brief Keyword Text View
None Type 2 Diabetes Mellitus View
None canakinumab View
None Pre diabetic View
None glucose intolerant View
None oral anti diabetic medication View
None insulin treatment View
None metabolic syndrome View